Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma
David J. Straus, Madeleine Duvic, Timothy M. Kuzel, et al.
Cancer (2007) Vol. 109, Iss. 9, pp. 1799-1803
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
Franz Trautinger, Johanna Eder, Chalid Assaf, et al.
European Journal of Cancer (2017) Vol. 77, pp. 57-74
Open Access | Times Cited: 419
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Sarah I. Jawed, Patricia L. Myskowski, Steven Horwitz, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 2, pp. 205.e1-205.e16
Closed Access | Times Cited: 353
Retinoic acid receptors: From molecular mechanisms to cancer therapy
Alessandra di Masi, Loris Leboffe, Elisabetta De Marinis, et al.
Molecular Aspects of Medicine (2014) Vol. 41, pp. 1-115
Closed Access | Times Cited: 342
Non-Hodgkin’s Lymphomas
Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani, et al.
Journal of the National Comprehensive Cancer Network (2010) Vol. 8, Iss. 3, pp. 288-334
Open Access | Times Cited: 338
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Sarah I. Jawed, Patricia L. Myskowski, Sarah McCue Horwitz, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 2, pp. 223.e1-223.e17
Closed Access | Times Cited: 326
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
Elise A. Olsen, Alain H. Rook, John A. Zic, et al.
Journal of the American Academy of Dermatology (2010) Vol. 64, Iss. 2, pp. 352-404
Closed Access | Times Cited: 161
Retinoids and rexinoids in cancer prevention: from laboratory to clinic
Iván P. Uray, Ethan Dmitrovsky, Powel H. Brown
Seminars in Oncology (2015) Vol. 43, Iss. 1, pp. 49-64
Open Access | Times Cited: 143
Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2017) Vol. 92, Iss. 10, pp. 1085-1102
Open Access | Times Cited: 141
Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 151-165
Open Access | Times Cited: 139
British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018
D. Gilson, Sean Whittaker, Fiona Child, et al.
British Journal of Dermatology (2018) Vol. 180, Iss. 3, pp. 496-526
Closed Access | Times Cited: 131
Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2019) Vol. 94, Iss. 9, pp. 1027-1041
Open Access | Times Cited: 118
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Neha Mehta‐Shah, Sarah McCue Horwitz, Stephen M. Ansell, et al.
Journal of the National Comprehensive Cancer Network (2020) Vol. 18, Iss. 5, pp. 522-536
Open Access | Times Cited: 102
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 193-209
Open Access | Times Cited: 51
U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma
Julia Scarisbrick, Stephen Morris, Richard Azurdia, et al.
British Journal of Dermatology (2012) Vol. 168, Iss. 1, pp. 192-200
Closed Access | Times Cited: 97
Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2014) Vol. 89, Iss. 8, pp. 837-851
Open Access | Times Cited: 67
Bexarotene: a promising anticancer agent
Liyan Qu, Xiuwen Tang
Cancer Chemotherapy and Pharmacology (2009) Vol. 65, Iss. 2, pp. 201-205
Closed Access | Times Cited: 71
Cutaneous T‐cell lymphoma: 2011 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2011) Vol. 86, Iss. 11, pp. 928-948
Open Access | Times Cited: 71
The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma
Natalie Spaccarelli, Alain H. Rook
Dermatologic Clinics (2015) Vol. 33, Iss. 4, pp. 731-745
Open Access | Times Cited: 63
Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome
Louise Photiou, Carrie Van Der Weyden, Christopher McCormack, et al.
Current Oncology Reports (2018) Vol. 20, Iss. 4
Closed Access | Times Cited: 57
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, et al.
Critical Reviews in Oncology/Hematology (2016) Vol. 99, pp. 214-227
Open Access | Times Cited: 47
Cutaneous B‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2020) Vol. 95, Iss. 10, pp. 1209-1213
Open Access | Times Cited: 39
Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2021) Vol. 96, Iss. 10, pp. 1313-1328
Open Access | Times Cited: 38
Cutaneous T Cell Lymphoma: Update of Treatment
H. S. Zackheim
Dermatology (1999) Vol. 199, Iss. 2, pp. 102-105
Closed Access | Times Cited: 90
The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma
Auris Huen, Ellen J. Kim
Dermatologic Clinics (2015) Vol. 33, Iss. 4, pp. 715-729
Open Access | Times Cited: 47
Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome
M. Polansky, Rakhshandra Talpur, Seema Daulat, et al.
Clinical Lymphoma Myeloma & Leukemia (2014) Vol. 15, Iss. 5, pp. e83-e93
Closed Access | Times Cited: 45
Page 1 - Next Page

Scroll to top